Arcutis Biotherapeutics (ARQT) Change in Account Payables (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Change in Account Payables of $5.6 million for Q1 2026, up 1716.5% year-over-year from $309000.0 in Q1 2025, and down 16.61% quarter-over-quarter from $6.7 million in Q4 2025.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Change in Account Payables (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Change in Account Payables history runs 8 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 1716.5% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $3.6 million (up 133.51% YoY), while the FY2025 annual figure was -$1.7 million, down 176.0% from the prior year.
- Change in Account Payables for Q1 2026 stood at $5.6 million, down from $6.7 million in the prior quarter.
- The five-year high for Change in Account Payables was $6.7 million in Q4 2025, with the low at -$9.3 million in Q3 2025.
- The 5-year median for Change in Account Payables is $309000.0 (2025), against an average of $639117.6.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables tumbled 1931.34% in 2023, then soared 6510.48% in 2025.
- Arcutis Biotherapeutics' Change in Account Payables stood at $182000.0 in 2022, then slumped by 755.49% to -$1.2 million in 2023, then surged by 91.2% to -$105000.0 in 2024, then jumped by 6510.48% to $6.7 million in 2025, then decreased by 16.61% to $5.6 million in 2026.
- Business Quant data shows ARQT's Change in Account Payables at $5.6 million in Q1 2026, $6.7 million in Q4 2025, and -$9.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arcutis Biotherapeutics | 3.12 Bn | 2.88 Bn | 118.92 Mn | -11.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.54 Mn |
| Mar 31, 2026 | 5.61 Mn |
| Dec 31, 2025 | 6.73 Mn |
| Sep 30, 2025 | -9.29 Mn |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | -105,000.00 |
| Sep 30, 2024 | 6.51 Mn |
| Jun 30, 2024 | -5.16 Mn |
| Mar 31, 2024 | 992,000.00 |
| Dec 31, 2023 | -1.19 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 3.38 Mn |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 217,000.00 |
| Jun 30, 2022 | -4.03 Mn |
| Mar 31, 2022 | 5.20 Mn |
| Dec 31, 2021 | 2.39 Mn |
| Sep 30, 2021 | 2.24 Mn |